Download PDF
Thromb Haemost 2022; 122(06): 1006-1016
DOI: 10.1055/a-1667-7293
Stroke, Systemic or Venous Thromboembolism

Prevalence of Bleeding and Thrombosis in Critically Ill Patients with Chronic Liver Disease

Tsai-Wing Ow
1   Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom
,
Evangelia Fatourou
1   Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom
,
Liane Rabinowich
1   Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom
,
Bente van den Boom
1   Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom
2   Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
,
Shrijit Nair
1   Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom
,
Vishal C. Patel
1   Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom
3   School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, Strand, London, United Kingdom
4   Institute of Hepatology, Foundation for Liver Research, London, United Kingdom
,
Brian Hogan
1   Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom
,
Mark McPhail
1   Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom
3   School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, Strand, London, United Kingdom
,
Lara N. Roberts    *
5   Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom
,
William Bernal   *
1   Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom
3   School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, Strand, London, United Kingdom
› Author Affiliations Funding None.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Introduction Hemorrhage and venous thromboembolism (VTE) are recognized complications of chronic liver disease (CLD), but their prevalence and risk factors in critically ill patients are uncertain.

Patients and Methods We studied a retrospective cohort of patients with CLD nonelectively admitted to a specialist intensive care unit (ICU) determining the prevalence and timing of major bleeding and VTE (early, present on admission/diagnosed within 48 hours; later, diagnosed >48 hours post-ICU admission). Associations with baseline clinical and laboratory characteristics, multiorgan failure (MOF), blood product administration, and mortality were explored. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression.

Results Of 623 patients with median age 52, bleeding (>48 hours after admission) occurred in 87 (14%) patients. Bleeding was associated with greater illness severity and increased mortality. Gastrointestinal bleeding accounted for 72% of events, secondary to portal hypertension in >90%. Procedure-related bleeding was uncommon. VTE occurred in 125 (20%) patients: early VTE in 80 (13%) and involving the portal vein in 85%. Later VTE affected 45 (7.2%) patients. Hepatocellular carcinoma (HCC) and nonalcoholic liver disease were independently associated with early VTE (OR: 2.79, 95% CI: 1.5–5.2 and OR: 2.32, 95% CI: 1.4–3.9, respectively), and HCC, sepsis, and cryoprecipitate use with late VTE (OR: 2.45, 95% CI: 1.11–5.43; OR: 2.26, 95% CI: 1.2–4.3; and OR: 2.60, 95% CI: 1.3–5.1).

Conclusion VTE was prevalent on admission to critical care and less commonly developed later. Bleeding was associated with MOF and increased mortality. Severe MOF was not associated with an increased rate of VTE which was linked with HCC, and specific etiologies of CLD.

Keywords

liver disease - critical care - hemorrhage - venous thromboembolism

Author Contributions

W.B. conceived and supervised the study and design, data analysis and interpretation, and critical review of the paper. T.-W.O. led data collection, interpretation, and writing of the manuscript. L.N.R. contributed to study design, data interpretation, and writing of the manuscript. E.F., L.R., S.N., and B.v.d.B. collected data. V.C.P., B.H., and M.M. interpreted the data and critically reviewed the manuscript. All authors revised and approved the final submission.


* Co-joint senior authors.


Supplementary Material



Publication History

Received: 17 March 2021

Accepted: 10 October 2021

Accepted Manuscript online:
12 October 2021

Article published online:
28 December 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44 (01) 217-231
    Google Scholar
  • 2 Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure. N Engl J Med 2020; 382 (22) 2137-2145
    Google Scholar
  • 3 Arroyo V, Moreau R, Jalan R, Ginès P. EASL-CLIF Consortium CANONIC Study. Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis. J Hepatol 2015; 62 (1, Suppl): S131-S143
    CrossrefPubMedGoogle Scholar
  • 4 Jalan R, Saliba F, Pavesi M. et al; CANONIC study investigators of the EASL-CLIF Consortium. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol 2014; 61 (05) 1038-1047
    Google Scholar
  • 5 Fisher C, Patel VC, Stoy SH. et al. Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure. J Crit Care 2018; 43: 54-60
    CrossrefPubMedGoogle Scholar
  • 6 Zanetto A, Rinder HM, Campello E. et al. Acute kidney injury in decompensated cirrhosis is associated with both hypo- and hyper-coagulable features. Hepatology 2020; 72 (04) 1327-1340
    CrossrefPubMedGoogle Scholar
  • 7 Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010; 116 (06) 878-885
    CrossrefPubMedGoogle Scholar
  • 8 Basili S, Raparelli V, Napoleone L. et al; PRO-LIVER Collaborators. Platelet count does not predict bleeding in cirrhotic patients: results from the PRO-LIVER study. Am J Gastroenterol 2018; 113 (03) 368-375
    CrossrefPubMedGoogle Scholar
  • 9 Shah NL, Northup PG, Caldwell SH. A clinical survey of bleeding, thrombosis, and blood product use in decompensated cirrhosis patients. Ann Hepatol 2012; 11 (05) 686-690
    CrossrefPubMedGoogle Scholar
  • 10 Montenovo M, Rahnemai-Azar A, Reyes J, Perkins J. Clinical impact and risk factors for portal vein thrombosis for patients on wait list for liver transplant. Exp Clin Transplant 2018; 16 (02) 166-171
    PubMedGoogle Scholar
  • 11 Gulley D, Teal E, Suvannasankha A, Chalasani N, Liangpunsakul S. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci 2008; 53 (11) 3012-3017
    CrossrefPubMedGoogle Scholar
  • 12 Dabbagh O, Oza A, Prakash S, Sunna R, Saettele TM. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest 2010; 137 (05) 1145-1149
    CrossrefPubMedGoogle Scholar
  • 13 Blasi A, Patel VC, Adelmeijer J. et al. Mixed fibrinolytic phenotypes in decompensated cirrhosis and acute-on-chronic liver failure with hypofibrinolysis in those with complications and poor survival. Hepatology 2020; 71 (04) 1381-1390
    Google Scholar
  • 14 Montalto P, Vlachogiannakos J, Cox DJ, Pastacaldi S, Patch D, Burroughs AK. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 2002; 37 (04) 463-470
    CrossrefPubMedGoogle Scholar
  • 15 Roberts LN, Bernal W. Incidence of bleeding and thrombosis in patients with liver disease. Semin Thromb Hemost 2020; 46 (06) 656-664
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Drolz A, Horvatits T, Roedl K. et al. Coagulation parameters and major bleeding in critically ill patients with cirrhosis. Hepatology 2016; 64 (02) 556-568
    CrossrefPubMedGoogle Scholar
  • 17 Moreau R, Jalan R, Gines P. et al; CANONIC Study Investigators of the EASL–CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144 (07) 1426-1437
    Google Scholar
  • 18 Jalan R, Pavesi M, Saliba F. et al; CANONIC Study Investigators; EASL-CLIF Consortium. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. J Hepatol 2015; 62 (04) 831-840
    CrossrefPubMedGoogle Scholar
  • 19 Schulman S, Angerås U, Bergqvist D, Eriksson B, Lassen MR, Fisher W. Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 2010; 8 (01) 202-204
    CrossrefPubMedGoogle Scholar
  • 20 Roberts LN, Porter G, Barker RD. et al. Comprehensive VTE prevention program incorporating mandatory risk assessment reduces the incidence of hospital-associated thrombosis. Chest 2013; 144 (04) 1276-1281
    CrossrefPubMedGoogle Scholar
  • 21 Intagliata NM, Henry ZH, Shah N, Lisman T, Caldwell SH, Northup PG. Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding. Liver Int 2014; 34 (01) 26-32
    CrossrefPubMedGoogle Scholar
  • 22 Desborough MJ, Hockley B, Sekhar M, Burroughs AK, Stanworth SJ, Jairath V. National Audit Collaborative. Patterns of blood component use in cirrhosis: a nationwide study. Liver Int 2016; 36 (04) 522-529
    CrossrefPubMedGoogle Scholar
  • 23 Patel IJ, Rahim S, Davidson JC. et al. Society of Interventional Radiology Consensus Guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions-part ii: recommendations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol 2019; 30 (08) 1168.e1-1184.e1
    CrossrefPubMedGoogle Scholar
  • 24 De Pietri L, Bianchini M, Montalti R. et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology 2016; 63 (02) 566-573
    Google Scholar
  • 25 Vuyyuru SK, Singh AD, Gamanagatti SR, Rout G, Shalimar GD. A randomized control trial of thromboelastography-guided transfusion in cirrhosis for high-risk invasive liver-related procedures. Dig Dis Sci 2020; 65 (07) 2104-2111
    CrossrefPubMedGoogle Scholar
  • 26 O'Leary JG, Greenberg CS, Patton HM, Caldwell SH. AGA clinical practice update: coagulation in cirrhosis. Gastroenterology 2019; 157 (01) 34.e1-43.e1
    CrossrefPubMedGoogle Scholar
  • 27 Villanueva C, Colomo A, Bosch A. et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368 (01) 11-21
    Google Scholar
  • 28 Jairath V, Harrison P, Stanworth S. et al. Thrombin generation is normal in cirrhotics with acute variceal haemorrhage: results from a prospective study. Gut 2012; 61 (Suppl. 02) A418-A418
    CrossrefPubMedGoogle Scholar
  • 29 Cook D, Meade M, Guyatt G. et al; PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 2011; 364 (14) 1305-1314
    CrossrefPubMedGoogle Scholar
  • 30 Stine JG, Shah NL, Argo CK, Pelletier SJ, Caldwell SH, Northup PG. Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis. Liver Transpl 2015; 21 (08) 1016-1021
    CrossrefPubMedGoogle Scholar
  • 31 Bezinover D, Iskandarani K, Chinchilli V. et al. Autoimmune conditions are associated with perioperative thrombotic complications in liver transplant recipients: a UNOS database analysis. BMC Anesthesiol 2016; 16 (01) 26
    CrossrefPubMedGoogle Scholar
  • 32 Kaplan D, Casper TC, Elliott CG. et al. VTE incidence and risk factors in patients with severe sepsis and septic shock. Chest 2015; 148 (05) 1224-1230
    CrossrefPubMedGoogle Scholar
  • 33 Reynolds PM, Van Matre ET, Wright GC. et al; Colorado Pulmonary Outcomes Research Group (CPOR). Evaluation of prophylactic heparin dosage strategies and risk factors for venous thromboembolism in the critically ill patient. Pharmacotherapy 2019; 39 (03) 232-241
    CrossrefPubMedGoogle Scholar
  • 34 Zocco MA, Di Stasio E, De Cristofaro R. et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009; 51 (04) 682-689
    CrossrefPubMedGoogle Scholar
  • 35 Abdel-Razik A, Mousa N, Elhelaly R, Tawfik A. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system. Eur J Gastroenterol Hepatol 2015; 27 (05) 585-592
    CrossrefPubMedGoogle Scholar
  • 36 Stine JG, Shah PM, Cornella SL. et al. Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis. World J Hepatol 2015; 7 (27) 2774-2780
    CrossrefPubMedGoogle Scholar
  • 37 Violi F, Corazza GR, Caldwell SH. et al; PRO-LIVER Collaborative Group. Incidence and recurrence of portal vein thrombosis in cirrhotic patients. Thromb Haemost 2019; 119 (03) 496-499
    Article in Thieme ConnectPubMedGoogle Scholar
  • 38 Emuakhagbon V, Philips P, Agopian V, Kaldas FM, Jones CM. Incidence and risk factors for deep venous thrombosis and pulmonary embolus after liver transplantation. Am J Surg 2016; 211 (04) 768-771
    CrossrefPubMedGoogle Scholar
  • 39 Nguyen-Buckley C, Gao W, Agopian V. et al. Major thromboembolic complications in liver transplantation: the role of rotational thromboelastometry and cryoprecipitate transfusion. Transplantation 2021; 105 (08) 1771-1777
    CrossrefPubMedGoogle Scholar
  • 40 Jairath V, Rehal S, Logan R. et al. Acute variceal haemorrhage in the United Kingdom: patient characteristics, management and outcomes in a nationwide audit. Dig Liver Dis 2014; 46 (05) 419-426
    CrossrefPubMedGoogle Scholar
  • 41 Budnick IM, Davis JPE, Sundararaghavan A. et al. Transfusion with cryoprecipitate for very low fibrinogen levels does not affect bleeding or survival in critically ill cirrhosis patients. Thromb Haemost 2021; 121 (10) 1317-1325
    Article in Thieme ConnectPubMedGoogle Scholar